CGEN
Compugen
2.30$
+0.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +79.5% | -6.3% | -3.1% | +12.1% | -6.9% | +0.4% | -7.7% | -8.1% | +60.0% | -6.8% | -5.1% | |
| – | +90.1% | -7.9% | -3.3% | +12.4% | -7.7% | +0.8% | -8.7% | -8.9% | +66.5% | -7.3% | -5.7% | |
| – | -70.9% | +397.1% | -82.8% | -39.2% | +152.6% | -20.0% | -55.6% | +15.3% | +1,115.3% | -86.3% | -17.3% | |
| – | -11.9% | +99.9% | -9.2% | +22.5% | -8.4% | +0.5% | -9.5% | -8.3% | +69.2% | -7.3% | -7.1% | |
| – | +2,119.3% | -93.1% | +130.0% | -78.3% | -87.3% | +1,070.3% | +19.6% | -24.8% | -89.6% | +695.2% | +75.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +287.8% | -3.1% | -4.1% | +21.6% | -4.7% | -2.9% | -3.5% | -4.0% | -0.3% | -6.2% | -1.7% | |
| – | +153.1% | -6.2% | +0.6% | +12.1% | -27.4% | +4.1% | -2.0% | -1.5% | +11.3% | -2.4% | +2.7% | |
| – | +6.8% | -30.2% | +1.8% | -0.4% | +0.2% | -5.6% | +11.3% | +3.2% | +7.2% | +7.3% | +11.4% | |
| – | -64.2% | +283.6% | -82.3% | +379.4% | -83.9% | +495.4% | -83.6% | +409.3% | -74.2% | +7.4% | -14.7% | |
| – | +23.2% | -9.0% | -2.2% | +3.7% | -9.2% | +4.0% | -12.0% | -12.8% | +134.4% | -7.2% | -6.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.1% | +1.2% | +0.0% | +0.3% | -0.3% | +3.1% | +1.3% | +0.0% | +1.3% | -0.2% | +0.1% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.